Sweden
· Delayed Price · Currency is SEK Episurf Medical AB Statistics
Total Valuation
STO:EPIS.B has a market cap or net worth of SEK 70.14 million. The enterprise value is 44.14 million.
| Market Cap | 70.14M |
| Enterprise Value | 44.14M |
Important Dates
The last earnings date was Thursday, April 10, 2025.
| Earnings Date | Apr 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:EPIS.B has 653.06 million shares outstanding. The number of shares has increased by 77.67% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 653.06M |
| Shares Change (YoY) | +77.67% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 16.60% |
| Owned by Institutions (%) | 28.58% |
| Float | 468.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.05 |
| PB Ratio | 1.04 |
| P/TBV Ratio | 1.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.61 |
| EV / Sales | 1.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.83, with a Debt / Equity ratio of 0.10.
| Current Ratio | 2.83 |
| Quick Ratio | 2.39 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -81.11 |
Financial Efficiency
Return on equity (ROE) is -109.57% and return on invested capital (ROIC) is -63.86%.
| Return on Equity (ROE) | -109.57% |
| Return on Assets (ROA) | -54.35% |
| Return on Invested Capital (ROIC) | -63.86% |
| Return on Capital Employed (ROCE) | -103.11% |
| Revenue Per Employee | 851,852 |
| Profits Per Employee | -2.67M |
| Employee Count | 27 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 15.32 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.20% in the last 52 weeks. The beta is 1.17, so STO:EPIS.B's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | -69.20% |
| 50-Day Moving Average | 0.12 |
| 200-Day Moving Average | 0.15 |
| Relative Strength Index (RSI) | 40.56 |
| Average Volume (20 Days) | 1,794,045 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:EPIS.B had revenue of SEK 23.00 million and -72.10 million in losses. Loss per share was -0.13.
| Revenue | 23.00M |
| Gross Profit | -26.80M |
| Operating Income | -73.00M |
| Pretax Income | -71.70M |
| Net Income | -72.10M |
| EBITDA | -70.70M |
| EBIT | -73.00M |
| Loss Per Share | -0.13 |
Balance Sheet
The company has 32.60 million in cash and 6.60 million in debt, giving a net cash position of 26.00 million or 0.04 per share.
| Cash & Cash Equivalents | 32.60M |
| Total Debt | 6.60M |
| Net Cash | 26.00M |
| Net Cash Per Share | 0.04 |
| Equity (Book Value) | 67.20M |
| Book Value Per Share | 0.10 |
| Working Capital | 27.50M |
Cash Flow
| Operating Cash Flow | -64.10M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | -116.52% |
| Operating Margin | -317.39% |
| Pretax Margin | -311.74% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:EPIS.B does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -77.67% |
| Shareholder Yield | -77.67% |
| Earnings Yield | -102.80% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 20, 2011. It was a reverse split with a ratio of 0.1666666667.
| Last Split Date | Jul 20, 2011 |
| Split Type | Reverse |
| Split Ratio | 0.1666666667 |
Scores
STO:EPIS.B has an Altman Z-Score of -11.31. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.31 |
| Piotroski F-Score | n/a |